Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.05162357 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.05162357 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.80225059 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.80225059 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.41588086 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.19037823 |
7 | kynurenine metabolic process (GO:0070189) | 5.89203801 |
8 | low-density lipoprotein particle clearance (GO:0034383) | 5.88131283 |
9 | tryptophan catabolic process (GO:0006569) | 5.87134989 |
10 | indole-containing compound catabolic process (GO:0042436) | 5.87134989 |
11 | indolalkylamine catabolic process (GO:0046218) | 5.87134989 |
12 | alpha-linolenic acid metabolic process (GO:0036109) | 5.84780817 |
13 | bile acid biosynthetic process (GO:0006699) | 5.74088044 |
14 | glyoxylate metabolic process (GO:0046487) | 5.52767076 |
15 | sulfur amino acid catabolic process (GO:0000098) | 5.52644619 |
16 | tryptophan metabolic process (GO:0006568) | 5.49181836 |
17 | urea cycle (GO:0000050) | 5.43708431 |
18 | urea metabolic process (GO:0019627) | 5.43708431 |
19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.34490215 |
20 | negative regulation of fibrinolysis (GO:0051918) | 5.22660176 |
21 | cysteine metabolic process (GO:0006534) | 5.15597406 |
22 | complement activation, alternative pathway (GO:0006957) | 5.15510072 |
23 | regulation of protein activation cascade (GO:2000257) | 5.08486354 |
24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.07121232 |
25 | protein carboxylation (GO:0018214) | 5.07121232 |
26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.01151011 |
27 | nitrogen cycle metabolic process (GO:0071941) | 4.98348837 |
28 | serine family amino acid catabolic process (GO:0009071) | 4.97738290 |
29 | regulation of fibrinolysis (GO:0051917) | 4.97355050 |
30 | regulation of triglyceride catabolic process (GO:0010896) | 4.94569824 |
31 | bile acid metabolic process (GO:0008206) | 4.92053730 |
32 | regulation of complement activation (GO:0030449) | 4.78853415 |
33 | lysine catabolic process (GO:0006554) | 4.77021047 |
34 | lysine metabolic process (GO:0006553) | 4.77021047 |
35 | homocysteine metabolic process (GO:0050667) | 4.73844360 |
36 | reverse cholesterol transport (GO:0043691) | 4.70817107 |
37 | diacylglycerol metabolic process (GO:0046339) | 4.70281175 |
38 | amino-acid betaine metabolic process (GO:0006577) | 4.67607308 |
39 | aromatic amino acid family metabolic process (GO:0009072) | 4.64166350 |
40 | negative regulation of sterol transport (GO:0032372) | 4.60087922 |
41 | negative regulation of cholesterol transport (GO:0032375) | 4.60087922 |
42 | regulation of cholesterol esterification (GO:0010872) | 4.59492145 |
43 | triglyceride homeostasis (GO:0070328) | 4.58373202 |
44 | acylglycerol homeostasis (GO:0055090) | 4.58373202 |
45 | vitamin transmembrane transport (GO:0035461) | 4.56455970 |
46 | macromolecular complex remodeling (GO:0034367) | 4.53358483 |
47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.53358483 |
48 | protein-lipid complex remodeling (GO:0034368) | 4.53358483 |
49 | fatty acid homeostasis (GO:0055089) | 4.50489261 |
50 | alpha-amino acid catabolic process (GO:1901606) | 4.47575643 |
51 | phospholipid efflux (GO:0033700) | 4.43119514 |
52 | tyrosine metabolic process (GO:0006570) | 4.42049376 |
53 | NADH metabolic process (GO:0006734) | 4.32946089 |
54 | ethanol oxidation (GO:0006069) | 4.30544017 |
55 | glycine metabolic process (GO:0006544) | 4.28961869 |
56 | cellular ketone body metabolic process (GO:0046950) | 4.28445161 |
57 | plasma lipoprotein particle clearance (GO:0034381) | 4.26601623 |
58 | bile acid and bile salt transport (GO:0015721) | 4.25958086 |
59 | coenzyme catabolic process (GO:0009109) | 4.22286288 |
60 | cellular amino acid catabolic process (GO:0009063) | 4.17761534 |
61 | regulation of cholesterol homeostasis (GO:2000188) | 4.12426926 |
62 | cellular glucuronidation (GO:0052695) | 4.11588735 |
63 | benzene-containing compound metabolic process (GO:0042537) | 4.10480060 |
64 | cholesterol efflux (GO:0033344) | 4.09718918 |
65 | indolalkylamine metabolic process (GO:0006586) | 4.06766024 |
66 | glutamate metabolic process (GO:0006536) | 4.05757842 |
67 | ethanol metabolic process (GO:0006067) | 4.03981388 |
68 | serine family amino acid metabolic process (GO:0009069) | 4.03071581 |
69 | cellular modified amino acid catabolic process (GO:0042219) | 4.02847302 |
70 | imidazole-containing compound metabolic process (GO:0052803) | 3.99121520 |
71 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.98177391 |
72 | plasma lipoprotein particle assembly (GO:0034377) | 3.96965682 |
73 | drug catabolic process (GO:0042737) | 3.96808638 |
74 | cellular biogenic amine catabolic process (GO:0042402) | 3.93833286 |
75 | amine catabolic process (GO:0009310) | 3.93833286 |
76 | positive regulation of lipid catabolic process (GO:0050996) | 3.87228195 |
77 | acetyl-CoA metabolic process (GO:0006084) | 3.86615701 |
78 | triglyceride catabolic process (GO:0019433) | 3.86235296 |
79 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.81564582 |
80 | serine family amino acid biosynthetic process (GO:0009070) | 3.81067094 |
81 | regulation of bile acid biosynthetic process (GO:0070857) | 3.80135763 |
82 | cholesterol homeostasis (GO:0042632) | 3.79375715 |
83 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.79231615 |
84 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.79231615 |
85 | phospholipid homeostasis (GO:0055091) | 3.77729669 |
86 | arginine metabolic process (GO:0006525) | 3.76218563 |
87 | neutral lipid catabolic process (GO:0046461) | 3.75754751 |
88 | acylglycerol catabolic process (GO:0046464) | 3.75754751 |
89 | short-chain fatty acid metabolic process (GO:0046459) | 3.75702920 |
90 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.74974728 |
91 | epoxygenase P450 pathway (GO:0019373) | 3.73485578 |
92 | sterol homeostasis (GO:0055092) | 3.73286482 |
93 | complement activation, classical pathway (GO:0006958) | 3.72396831 |
94 | organic acid catabolic process (GO:0016054) | 3.71408527 |
95 | carboxylic acid catabolic process (GO:0046395) | 3.71408527 |
96 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.70855647 |
97 | ketone body metabolic process (GO:1902224) | 3.70302123 |
98 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.66968541 |
99 | cytolysis (GO:0019835) | 3.66527192 |
100 | fibrinolysis (GO:0042730) | 3.66430470 |
101 | complement activation (GO:0006956) | 3.65050037 |
102 | flavonoid metabolic process (GO:0009812) | 3.63765111 |
103 | fatty acid beta-oxidation (GO:0006635) | 3.63728641 |
104 | 2-oxoglutarate metabolic process (GO:0006103) | 3.62904682 |
105 | intestinal cholesterol absorption (GO:0030299) | 3.62368854 |
106 | protein-lipid complex assembly (GO:0065005) | 3.60827224 |
107 | regulation of cholesterol storage (GO:0010885) | 3.59192517 |
108 | fatty acid oxidation (GO:0019395) | 3.58751727 |
109 | glucuronate metabolic process (GO:0019585) | 3.58525462 |
110 | uronic acid metabolic process (GO:0006063) | 3.58525462 |
111 | negative regulation of lipase activity (GO:0060192) | 3.57729629 |
112 | intestinal absorption (GO:0050892) | 3.54837744 |
113 | plasma lipoprotein particle organization (GO:0071827) | 3.53996909 |
114 | monocarboxylic acid catabolic process (GO:0072329) | 3.52796526 |
115 | regulation of cholesterol metabolic process (GO:0090181) | 3.52275050 |
116 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.41148870 |
117 | protein-lipid complex subunit organization (GO:0071825) | 3.40248662 |
118 | low-density lipoprotein particle remodeling (GO:0034374) | 3.33177498 |
119 | oxaloacetate metabolic process (GO:0006107) | 3.33024926 |
120 | oligosaccharide catabolic process (GO:0009313) | 3.29965117 |
121 | triglyceride biosynthetic process (GO:0019432) | 3.29951410 |
122 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.26054840 |
123 | acylglycerol biosynthetic process (GO:0046463) | 3.22383491 |
124 | neutral lipid biosynthetic process (GO:0046460) | 3.22383491 |
125 | proline metabolic process (GO:0006560) | 3.18208930 |
126 | lipoprotein metabolic process (GO:0042157) | 3.17830934 |
127 | regulation of apoptotic cell clearance (GO:2000425) | 3.17709534 |
128 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.12919431 |
129 | triglyceride metabolic process (GO:0006641) | 3.12137275 |
130 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.09342118 |
131 | desmosome organization (GO:0002934) | 3.07887839 |
132 | regulation of triglyceride metabolic process (GO:0090207) | 3.01988219 |
133 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.01952686 |
134 | acylglycerol metabolic process (GO:0006639) | 2.99741734 |
135 | angiotensin maturation (GO:0002003) | 2.99490982 |
136 | neutral lipid metabolic process (GO:0006638) | 2.93945570 |
137 | regulation of sequestering of triglyceride (GO:0010889) | 2.93073061 |
138 | biotin metabolic process (GO:0006768) | 2.91456936 |
139 | tricarboxylic acid metabolic process (GO:0072350) | 2.90690614 |
140 | primary alcohol metabolic process (GO:0034308) | 2.84171477 |
141 | carnitine shuttle (GO:0006853) | 2.83227943 |
142 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.82531768 |
143 | acyl-CoA biosynthetic process (GO:0071616) | 2.79261959 |
144 | thioester biosynthetic process (GO:0035384) | 2.79261959 |
145 | drug metabolic process (GO:0017144) | 2.79082522 |
146 | fatty acid transmembrane transport (GO:1902001) | 2.79074760 |
147 | very long-chain fatty acid metabolic process (GO:0000038) | 2.79033947 |
148 | positive regulation of lipid storage (GO:0010884) | 2.74303836 |
149 | positive regulation of steroid metabolic process (GO:0045940) | 2.74300526 |
150 | positive regulation of cholesterol efflux (GO:0010875) | 2.72256386 |
151 | negative regulation of fatty acid transport (GO:2000192) | 2.71968396 |
152 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.71546384 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.97071071 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.00649868 |
3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.22840811 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.11376304 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.58995276 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.97727880 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.49535772 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.98247196 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.46097475 |
10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.41242698 |
11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01905843 |
12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2143968 |
13 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.99155690 |
14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96442122 |
15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.75380759 |
16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.64351029 |
17 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59706512 |
18 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.59191673 |
19 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.58770703 |
20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.52464072 |
21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47557319 |
22 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39413147 |
23 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.38450755 |
24 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.34491772 |
25 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31775048 |
26 | P68_20966046_ChIP-Seq_HELA_Human | 1.29281129 |
27 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.26917149 |
28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.26349171 |
29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21190986 |
30 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20991920 |
31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.20962526 |
32 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.20920032 |
33 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20512875 |
34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20247825 |
35 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19366691 |
36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18423508 |
37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18242383 |
38 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17805768 |
39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16636679 |
40 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.16452079 |
41 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.15601119 |
42 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.15009366 |
43 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.11133236 |
44 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09390800 |
45 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07167801 |
46 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06813022 |
47 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06739887 |
48 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05979642 |
49 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05515201 |
50 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.05478160 |
51 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04619910 |
52 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04060132 |
53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03567164 |
54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03241490 |
55 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02067129 |
56 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02032211 |
57 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.01289601 |
58 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.00655744 |
59 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.99295569 |
60 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96847991 |
61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96542779 |
62 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96290883 |
63 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95546051 |
64 | SA1_27219007_Chip-Seq_Bcells_Human | 0.93478008 |
65 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91750013 |
66 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91371947 |
67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91108373 |
68 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.89966367 |
69 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.88864551 |
70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88616161 |
71 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88591469 |
72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87794965 |
73 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86787142 |
74 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.86325745 |
75 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.86269157 |
76 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.83037446 |
77 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81616487 |
78 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81491663 |
79 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.80462420 |
80 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.78979682 |
81 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.78295086 |
82 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.76703762 |
83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74973232 |
84 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74651297 |
85 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.73356550 |
86 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.72107738 |
87 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.71726231 |
88 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.69190498 |
89 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.68627257 |
90 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.68236471 |
91 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.67908927 |
92 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67855736 |
93 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.65766946 |
94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.64650576 |
95 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61648285 |
96 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.61535015 |
97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60496230 |
98 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.59176979 |
99 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.58340528 |
100 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.57711773 |
101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.57589859 |
102 | GATA1_19941826_ChIP-Seq_K562_Human | 0.56646363 |
103 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55537600 |
104 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55179640 |
105 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54683933 |
106 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54578524 |
107 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.54461747 |
108 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.53964873 |
109 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.53823301 |
110 | GATA2_19941826_ChIP-Seq_K562_Human | 0.53334316 |
111 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52489803 |
112 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.52275483 |
113 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.52275483 |
114 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.51668753 |
115 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51038524 |
116 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.50944129 |
117 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.49057593 |
118 | ATF3_27146783_Chip-Seq_COLON_Human | 0.49046677 |
119 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47925000 |
120 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47912563 |
121 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.47170495 |
122 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.46711394 |
123 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.45429784 |
124 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.45028355 |
125 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.44945085 |
126 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.44636748 |
127 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.44231817 |
128 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.44047710 |
129 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.43863439 |
130 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.43563257 |
131 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.43168790 |
132 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.43061519 |
133 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.42160681 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.95176145 |
2 | MP0005360_urolithiasis | 7.43879858 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.23208150 |
4 | MP0005365_abnormal_bile_salt | 6.01413626 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.98835068 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.99500526 |
7 | MP0003252_abnormal_bile_duct | 3.94299601 |
8 | MP0010329_abnormal_lipoprotein_level | 3.62575357 |
9 | MP0009840_abnormal_foam_cell | 3.37134304 |
10 | MP0005058_abnormal_lysosome_morphology | 3.03723944 |
11 | MP0001666_abnormal_nutrient_absorption | 2.73351217 |
12 | MP0005083_abnormal_biliary_tract | 2.72399972 |
13 | MP0005332_abnormal_amino_acid | 2.65664933 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.38360106 |
15 | MP0003195_calcinosis | 2.27514702 |
16 | MP0000609_abnormal_liver_physiology | 2.24203129 |
17 | MP0002118_abnormal_lipid_homeostasis | 2.11547183 |
18 | MP0004019_abnormal_vitamin_homeostasis | 2.02809500 |
19 | MP0005319_abnormal_enzyme/_coenzyme | 1.90430984 |
20 | MP0003705_abnormal_hypodermis_morpholog | 1.84670959 |
21 | MP0003868_abnormal_feces_composition | 1.79774705 |
22 | MP0002138_abnormal_hepatobiliary_system | 1.76356272 |
23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55610052 |
24 | MP0005409_darkened_coat_color | 1.39464407 |
25 | MP0001764_abnormal_homeostasis | 1.39025574 |
26 | MP0004782_abnormal_surfactant_physiolog | 1.36472132 |
27 | MP0000003_abnormal_adipose_tissue | 1.35731721 |
28 | MP0009643_abnormal_urine_homeostasis | 1.31449099 |
29 | MP0005451_abnormal_body_composition | 1.30730716 |
30 | MP0008438_abnormal_cutaneous_collagen | 1.26873081 |
31 | MP0000598_abnormal_liver_morphology | 1.23122115 |
32 | MP0000751_myopathy | 1.22915732 |
33 | MP0005670_abnormal_white_adipose | 1.22686523 |
34 | MP0003172_abnormal_lysosome_physiology | 1.22280878 |
35 | MP0009697_abnormal_copulation | 1.18504315 |
36 | MP0003186_abnormal_redox_activity | 1.15430883 |
37 | MP0004272_abnormal_basement_membrane | 1.12483482 |
38 | MP0005647_abnormal_sex_gland | 1.12282926 |
39 | MP0003011_delayed_dark_adaptation | 1.12218054 |
40 | MP0002254_reproductive_system_inflammat | 1.11338404 |
41 | MP0006138_congestive_heart_failure | 1.11086653 |
42 | MP0005330_cardiomyopathy | 1.10291863 |
43 | MP0010368_abnormal_lymphatic_system | 1.08268986 |
44 | MP0003656_abnormal_erythrocyte_physiolo | 1.07847503 |
45 | MP0000566_synostosis | 1.07085071 |
46 | MP0004043_abnormal_pH_regulation | 1.06119896 |
47 | MP0003183_abnormal_peptide_metabolism | 1.04267507 |
48 | MP0004130_abnormal_muscle_cell | 1.00476271 |
49 | MP0003959_abnormal_lean_body | 0.98264625 |
50 | MP0009763_increased_sensitivity_to | 0.94997028 |
51 | MP0000013_abnormal_adipose_tissue | 0.94105393 |
52 | MP0009764_decreased_sensitivity_to | 0.92938806 |
53 | MP0003950_abnormal_plasma_membrane | 0.87774633 |
54 | MP0000604_amyloidosis | 0.85944533 |
55 | MP0002971_abnormal_brown_adipose | 0.85898482 |
56 | MP0008469_abnormal_protein_level | 0.84707902 |
57 | MP0009642_abnormal_blood_homeostasis | 0.84638171 |
58 | MP0009053_abnormal_anal_canal | 0.81731215 |
59 | MP0005636_abnormal_mineral_homeostasis | 0.81711348 |
60 | MP0000858_altered_metastatic_potential | 0.81075905 |
61 | MP0002933_joint_inflammation | 0.80496293 |
62 | MP0010155_abnormal_intestine_physiology | 0.80349030 |
63 | MP0005666_abnormal_adipose_tissue | 0.79891674 |
64 | MP0006036_abnormal_mitochondrial_physio | 0.79741012 |
65 | MP0002098_abnormal_vibrissa_morphology | 0.76915380 |
66 | MP0002078_abnormal_glucose_homeostasis | 0.76626173 |
67 | MP0005334_abnormal_fat_pad | 0.75975597 |
68 | MP0005376_homeostasis/metabolism_phenot | 0.74228889 |
69 | MP0003566_abnormal_cell_adhesion | 0.73166293 |
70 | MP0001216_abnormal_epidermal_layer | 0.71518983 |
71 | MP0000639_abnormal_adrenal_gland | 0.70850555 |
72 | MP0003879_abnormal_hair_cell | 0.70351235 |
73 | MP0005165_increased_susceptibility_to | 0.69604859 |
74 | MP0005266_abnormal_metabolism | 0.69591734 |
75 | MP0002166_altered_tumor_susceptibility | 0.69224277 |
76 | MP0002089_abnormal_postnatal_growth/wei | 0.65716780 |
77 | MP0005164_abnormal_response_to | 0.65568997 |
78 | MP0009765_abnormal_xenobiotic_induced | 0.64714986 |
79 | MP0001661_extended_life_span | 0.64543603 |
80 | MP0001765_abnormal_ion_homeostasis | 0.64504772 |
81 | MP0005501_abnormal_skin_physiology | 0.64424351 |
82 | MP0001756_abnormal_urination | 0.64059820 |
83 | MP0005452_abnormal_adipose_tissue | 0.63413596 |
84 | MP0002132_abnormal_respiratory_system | 0.62879912 |
85 | MP0000747_muscle_weakness | 0.62717509 |
86 | MP0004264_abnormal_extraembryonic_tissu | 0.62015981 |
87 | MP0003279_aneurysm | 0.61174504 |
88 | MP0010234_abnormal_vibrissa_follicle | 0.61008652 |
89 | MP0005220_abnormal_exocrine_pancreas | 0.59857733 |
90 | MP0005448_abnormal_energy_balance | 0.59240403 |
91 | MP0009785_altered_susceptibility_to | 0.57986829 |
92 | MP0005535_abnormal_body_temperature | 0.57579787 |
93 | MP0000678_abnormal_parathyroid_gland | 0.57309462 |
94 | MP0005076_abnormal_cell_differentiation | 0.57177539 |
95 | MP0004087_abnormal_muscle_fiber | 0.56996720 |
96 | MP0005408_hypopigmentation | 0.55996317 |
97 | MP0002998_abnormal_bone_remodeling | 0.55467683 |
98 | MP0002796_impaired_skin_barrier | 0.55299398 |
99 | MP0005084_abnormal_gallbladder_morpholo | 0.55281581 |
100 | MP0002896_abnormal_bone_mineralization | 0.55272654 |
101 | MP0002136_abnormal_kidney_physiology | 0.55198941 |
102 | MP0009115_abnormal_fat_cell | 0.54996407 |
103 | MP0000343_altered_response_to | 0.54286606 |
104 | MP0001533_abnormal_skeleton_physiology | 0.53760118 |
105 | MP0002837_dystrophic_cardiac_calcinosis | 0.53669604 |
106 | MP0003690_abnormal_glial_cell | 0.53025765 |
107 | MP0003638_abnormal_response/metabolism_ | 0.52465019 |
108 | MP0003300_gastrointestinal_ulcer | 0.52098677 |
109 | MP0005248_abnormal_Harderian_gland | 0.52023459 |
110 | MP0004185_abnormal_adipocyte_glucose | 0.50931039 |
111 | MP0005464_abnormal_platelet_physiology | 0.48523223 |
112 | MP0006035_abnormal_mitochondrial_morpho | 0.47336191 |
113 | MP0002970_abnormal_white_adipose | 0.46815692 |
114 | MP0002822_catalepsy | 0.46596732 |
115 | MP0003453_abnormal_keratinocyte_physiol | 0.45025560 |
116 | MP0008874_decreased_physiological_sensi | 0.44825796 |
117 | MP0002876_abnormal_thyroid_physiology | 0.44742117 |
118 | MP0002928_abnormal_bile_duct | 0.43254079 |
119 | MP0008873_increased_physiological_sensi | 0.43006033 |
120 | MP0005395_other_phenotype | 0.42056200 |
121 | MP0009384_cardiac_valve_regurgitation | 0.42023774 |
122 | MP0002060_abnormal_skin_morphology | 0.41502137 |
123 | MP0009672_abnormal_birth_weight | 0.41067555 |
124 | MP0003953_abnormal_hormone_level | 0.40236942 |
125 | MP0000249_abnormal_blood_vessel | 0.39606528 |
126 | MP0003329_amyloid_beta_deposits | 0.39109259 |
127 | MP0000579_abnormal_nail_morphology | 0.38528842 |
128 | MP0005023_abnormal_wound_healing | 0.38021372 |
129 | MP0005166_decreased_susceptibility_to | 0.37481193 |
130 | MP0003436_decreased_susceptibility_to | 0.36334487 |
131 | MP0002168_other_aberrant_phenotype | 0.35858200 |
132 | MP0001853_heart_inflammation | 0.35515814 |
133 | MP0005375_adipose_tissue_phenotype | 0.34716678 |
134 | MP0003724_increased_susceptibility_to | 0.33606492 |
135 | MP0005167_abnormal_blood-brain_barrier | 0.33328808 |
136 | MP0002269_muscular_atrophy | 0.33247933 |
137 | MP0001243_abnormal_dermal_layer | 0.33227390 |
138 | MP0004947_skin_inflammation | 0.32967368 |
139 | MP0003075_altered_response_to | 0.32025696 |
140 | MP0008872_abnormal_physiological_respon | 0.31441308 |
141 | MP0000230_abnormal_systemic_arterial | 0.31111713 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.15131420 |
2 | Intrahepatic cholestasis (HP:0001406) | 7.05510989 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.89672611 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.53598770 |
5 | Hypobetalipoproteinemia (HP:0003563) | 6.20143804 |
6 | Xanthomatosis (HP:0000991) | 6.16698895 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 5.91216381 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.38461651 |
9 | Complement deficiency (HP:0004431) | 5.31947657 |
10 | Hyperammonemia (HP:0001987) | 4.79311104 |
11 | Hypolipoproteinemia (HP:0010981) | 4.74668104 |
12 | Hyperglycinemia (HP:0002154) | 4.42594565 |
13 | Epidermoid cyst (HP:0200040) | 4.42421264 |
14 | Hyperglycinuria (HP:0003108) | 4.35858039 |
15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.33144123 |
16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.31783648 |
17 | Ketosis (HP:0001946) | 4.29620216 |
18 | Joint hemorrhage (HP:0005261) | 4.28398640 |
19 | Hypoalphalipoproteinemia (HP:0003233) | 4.22696898 |
20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.20706591 |
21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.17826205 |
22 | Abnormality of glycine metabolism (HP:0010895) | 4.17826205 |
23 | Abnormality of the common coagulation pathway (HP:0010990) | 4.06649407 |
24 | Fat malabsorption (HP:0002630) | 3.98970515 |
25 | Hypoglycemic coma (HP:0001325) | 3.98252893 |
26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.95506564 |
27 | Abnormality of methionine metabolism (HP:0010901) | 3.90585880 |
28 | Abnormality of complement system (HP:0005339) | 3.87976434 |
29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.61462997 |
30 | Hypercholesterolemia (HP:0003124) | 3.58261569 |
31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.57682271 |
32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.56808905 |
33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.48855628 |
34 | Conjugated hyperbilirubinemia (HP:0002908) | 3.44477676 |
35 | Myocardial infarction (HP:0001658) | 3.19694321 |
36 | Ketoacidosis (HP:0001993) | 3.14355873 |
37 | Hyperbilirubinemia (HP:0002904) | 3.13098278 |
38 | Hypochromic microcytic anemia (HP:0004840) | 3.02476688 |
39 | Abnormality of nucleobase metabolism (HP:0010932) | 2.97259309 |
40 | Delayed CNS myelination (HP:0002188) | 2.95990739 |
41 | Steatorrhea (HP:0002570) | 2.94761767 |
42 | Vacuolated lymphocytes (HP:0001922) | 2.94703174 |
43 | Abnormality of serum amino acid levels (HP:0003112) | 2.90108989 |
44 | Dysostosis multiplex (HP:0000943) | 2.86776530 |
45 | Hepatocellular carcinoma (HP:0001402) | 2.84561585 |
46 | Skin nodule (HP:0200036) | 2.80985062 |
47 | Metabolic acidosis (HP:0001942) | 2.78828385 |
48 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.78231100 |
49 | Dicarboxylic aciduria (HP:0003215) | 2.78231100 |
50 | Exercise-induced myalgia (HP:0003738) | 2.71972446 |
51 | Spontaneous abortion (HP:0005268) | 2.65612635 |
52 | Abnormality of purine metabolism (HP:0004352) | 2.65157465 |
53 | Rhabdomyolysis (HP:0003201) | 2.64251560 |
54 | Vertebral compression fractures (HP:0002953) | 2.63661309 |
55 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.62244470 |
56 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.62244470 |
57 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.62244470 |
58 | Mucopolysacchariduria (HP:0008155) | 2.61927621 |
59 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.61927621 |
60 | Systemic lupus erythematosus (HP:0002725) | 2.61502999 |
61 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.59759184 |
62 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.59759184 |
63 | Abnormality of glycolipid metabolism (HP:0010969) | 2.59759184 |
64 | Spastic diplegia (HP:0001264) | 2.55362723 |
65 | Lethargy (HP:0001254) | 2.50823025 |
66 | Flat acetabular roof (HP:0003180) | 2.50584884 |
67 | Mitral stenosis (HP:0001718) | 2.47445516 |
68 | Neonatal onset (HP:0003623) | 2.47163533 |
69 | Myoglobinuria (HP:0002913) | 2.46179777 |
70 | Malnutrition (HP:0004395) | 2.42522936 |
71 | Acanthocytosis (HP:0001927) | 2.41748235 |
72 | Vascular calcification (HP:0004934) | 2.39245941 |
73 | Distal lower limb muscle weakness (HP:0009053) | 2.39177712 |
74 | Asymmetric septal hypertrophy (HP:0001670) | 2.38716188 |
75 | Esophageal varix (HP:0002040) | 2.38248467 |
76 | Gout (HP:0001997) | 2.37269574 |
77 | Abnormal gallbladder morphology (HP:0012437) | 2.32965166 |
78 | Cholelithiasis (HP:0001081) | 2.32345464 |
79 | Acanthosis nigricans (HP:0000956) | 2.31884526 |
80 | Abnormality of carpal bone ossification (HP:0006257) | 2.31662760 |
81 | Axonal loss (HP:0003447) | 2.30370245 |
82 | Hypoglycemic seizures (HP:0002173) | 2.28742754 |
83 | Right ventricular cardiomyopathy (HP:0011663) | 2.27296224 |
84 | Irritability (HP:0000737) | 2.25293132 |
85 | Abnormal gallbladder physiology (HP:0012438) | 2.21503521 |
86 | Cholecystitis (HP:0001082) | 2.21503521 |
87 | Hydroxyprolinuria (HP:0003080) | 2.20298398 |
88 | Abnormality of proline metabolism (HP:0010907) | 2.20298398 |
89 | Hemorrhage of the eye (HP:0011885) | 2.19685833 |
90 | Abnormal cartilage morphology (HP:0002763) | 2.18028055 |
91 | Glomerulonephritis (HP:0000099) | 2.17305864 |
92 | Sensorimotor neuropathy (HP:0007141) | 2.15290704 |
93 | Cardiovascular calcification (HP:0011915) | 2.15219501 |
94 | Late onset (HP:0003584) | 2.14417641 |
95 | Protrusio acetabuli (HP:0003179) | 2.13382406 |
96 | Pancreatitis (HP:0001733) | 2.09316919 |
97 | Gingival bleeding (HP:0000225) | 2.08675119 |
98 | Cerebral edema (HP:0002181) | 2.07832214 |
99 | Increased serum pyruvate (HP:0003542) | 2.07233167 |
100 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.06854613 |
101 | Vomiting (HP:0002013) | 2.04628977 |
102 | Amyloidosis (HP:0011034) | 2.04142575 |
103 | Nausea (HP:0002018) | 2.02735766 |
104 | Cervical subluxation (HP:0003308) | 2.02509882 |
105 | Brushfield spots (HP:0001088) | 1.99045289 |
106 | Menorrhagia (HP:0000132) | 1.98004438 |
107 | Purpura (HP:0000979) | 1.97694613 |
108 | Abnormal tarsal ossification (HP:0008369) | 1.97672346 |
109 | Generalized aminoaciduria (HP:0002909) | 1.96762158 |
110 | Pigmentary retinal degeneration (HP:0001146) | 1.96567134 |
111 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.95320047 |
112 | Growth hormone excess (HP:0000845) | 1.94397971 |
113 | Thrombophlebitis (HP:0004418) | 1.93849994 |
114 | Abnormal ossification of hand bones (HP:0005921) | 1.93003027 |
115 | Abnormality of the gallbladder (HP:0005264) | 1.92837515 |
116 | Cerebral aneurysm (HP:0004944) | 1.91643228 |
117 | Muscle stiffness (HP:0003552) | 1.91109822 |
118 | Stridor (HP:0010307) | 1.90560762 |
119 | Abnormality of glycolysis (HP:0004366) | 1.90063728 |
120 | Ulnar deviation of the wrist (HP:0003049) | 1.89878801 |
121 | Widely patent fontanelles and sutures (HP:0004492) | 1.89484463 |
122 | Poikilocytosis (HP:0004447) | 1.88999175 |
123 | J-shaped sella turcica (HP:0002680) | 1.88015757 |
124 | Enlarged kidneys (HP:0000105) | 1.87899563 |
125 | Polycythemia (HP:0001901) | 1.87500233 |
126 | Neonatal death (HP:0003811) | 1.86432591 |
127 | Protuberant abdomen (HP:0001538) | 1.86317091 |
128 | Abdominal distention (HP:0003270) | 1.84669189 |
129 | Thin bony cortex (HP:0002753) | 1.83306438 |
130 | Rickets (HP:0002748) | 1.82871034 |
131 | Abnormality of iron homeostasis (HP:0011031) | 1.82388860 |
132 | Hyperglycemia (HP:0003074) | 1.82348798 |
133 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81646830 |
134 | Opisthotonus (HP:0002179) | 1.81148381 |
135 | Ovoid vertebral bodies (HP:0003300) | 1.80503713 |
136 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80308600 |
137 | Increased cerebral lipofuscin (HP:0011813) | 1.79365633 |
138 | Abnormal hand bone ossification (HP:0010660) | 1.79201561 |
139 | Hypertriglyceridemia (HP:0002155) | 1.78633379 |
140 | Asymmetry of the thorax (HP:0001555) | 1.78456638 |
141 | Elevated hepatic transaminases (HP:0002910) | 1.77780345 |
142 | Nephritis (HP:0000123) | 1.76237602 |
143 | Facial shape deformation (HP:0011334) | 1.75201126 |
144 | Potter facies (HP:0002009) | 1.75201126 |
145 | Pathologic fracture (HP:0002756) | 1.74137490 |
146 | Abnormality of the periventricular white matter (HP:0002518) | 1.73868163 |
147 | Multiple lipomas (HP:0001012) | 1.73849058 |
148 | Abnormality of vitamin metabolism (HP:0100508) | 1.72398364 |
149 | Alkalosis (HP:0001948) | 1.71797167 |
150 | Renal cortical cysts (HP:0000803) | 1.71441149 |
151 | Pseudobulbar signs (HP:0002200) | 1.69552579 |
152 | Stroke (HP:0001297) | 1.69546027 |
153 | Cerebral palsy (HP:0100021) | 1.68827950 |
154 | Focal segmental glomerulosclerosis (HP:0000097) | 1.68803329 |
155 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.68611524 |
156 | Wide cranial sutures (HP:0010537) | 1.68527229 |
157 | Paraparesis (HP:0002385) | 1.68011652 |
158 | Increased serum ferritin (HP:0003281) | 1.67738466 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.73598444 |
2 | ERN1 | 5.02264931 |
3 | SIK1 | 4.29754242 |
4 | FGFR4 | 3.95764342 |
5 | TRIB3 | 3.23552394 |
6 | PKN2 | 2.82326446 |
7 | TAOK3 | 2.24161932 |
8 | MAP3K10 | 2.19506807 |
9 | MAPKAPK3 | 2.09773563 |
10 | BLK | 1.98269370 |
11 | ERBB4 | 1.89191907 |
12 | LATS1 | 1.84541348 |
13 | MST1R | 1.81366154 |
14 | INSRR | 1.78080416 |
15 | PTK6 | 1.76088730 |
16 | MAPK11 | 1.73620408 |
17 | FLT3 | 1.72646628 |
18 | GRK6 | 1.70689408 |
19 | TESK1 | 1.49491417 |
20 | TYK2 | 1.47038216 |
21 | NME2 | 1.46898810 |
22 | RIPK1 | 1.42181020 |
23 | MAP2K4 | 1.37433296 |
24 | KDR | 1.36795461 |
25 | ICK | 1.35749308 |
26 | SMG1 | 1.35254310 |
27 | MAP3K7 | 1.29863232 |
28 | CAMK1D | 1.29199901 |
29 | FGFR2 | 1.20548986 |
30 | FRK | 1.19813328 |
31 | MAP4K1 | 1.16279728 |
32 | CDK6 | 1.12802431 |
33 | EPHB1 | 1.12591202 |
34 | PRKAA2 | 1.11665427 |
35 | NEK9 | 1.10133924 |
36 | JAK1 | 1.08809179 |
37 | CDC42BPA | 1.06863140 |
38 | JAK2 | 1.04852906 |
39 | TGFBR2 | 1.04468949 |
40 | MAP2K3 | 1.01832884 |
41 | OBSCN | 0.99403002 |
42 | WNK4 | 0.98210515 |
43 | CDK12 | 0.96978329 |
44 | PIM2 | 0.96294194 |
45 | CSK | 0.95125172 |
46 | TBK1 | 0.92600598 |
47 | PIK3CG | 0.89345319 |
48 | TESK2 | 0.88453657 |
49 | TIE1 | 0.87481895 |
50 | ZAP70 | 0.83322072 |
51 | MAP3K11 | 0.82739116 |
52 | ERBB2 | 0.82094301 |
53 | MAPK15 | 0.81605825 |
54 | CSF1R | 0.81502201 |
55 | FGFR3 | 0.80424077 |
56 | MTOR | 0.79937776 |
57 | PDGFRA | 0.79534741 |
58 | CDK4 | 0.79246808 |
59 | BMX | 0.79124455 |
60 | TYRO3 | 0.77348930 |
61 | MAPK4 | 0.77140536 |
62 | PINK1 | 0.76511396 |
63 | PRPF4B | 0.75981556 |
64 | DYRK1B | 0.75913733 |
65 | MET | 0.75443952 |
66 | ABL2 | 0.75344310 |
67 | EEF2K | 0.73409951 |
68 | MAP3K3 | 0.73108155 |
69 | MAP3K1 | 0.71781175 |
70 | PRKAA1 | 0.70722064 |
71 | CAMK1G | 0.70698816 |
72 | PAK4 | 0.70301552 |
73 | MAPK12 | 0.69289373 |
74 | PDK2 | 0.69184863 |
75 | EPHA3 | 0.68547920 |
76 | AKT3 | 0.67799203 |
77 | ACVR1B | 0.66001178 |
78 | GSK3A | 0.65678250 |
79 | TRPM7 | 0.65543518 |
80 | PHKG2 | 0.64946651 |
81 | PHKG1 | 0.64946651 |
82 | PTK2 | 0.64596232 |
83 | MYLK | 0.64113709 |
84 | SGK3 | 0.62483266 |
85 | PRKCZ | 0.62269194 |
86 | LRRK2 | 0.62208799 |
87 | PRKACG | 0.59260640 |
88 | PDGFRB | 0.58024097 |
89 | IRAK3 | 0.57919868 |
90 | PRKD2 | 0.57896262 |
91 | PDK3 | 0.56953227 |
92 | PDK4 | 0.56953227 |
93 | STK38L | 0.56845336 |
94 | DAPK2 | 0.56636574 |
95 | EPHA2 | 0.56511700 |
96 | MAP3K2 | 0.56326754 |
97 | RPS6KL1 | 0.55115398 |
98 | RPS6KC1 | 0.55115398 |
99 | STK3 | 0.54858246 |
100 | MAPK7 | 0.54469656 |
101 | ARAF | 0.53566882 |
102 | PDPK1 | 0.50109979 |
103 | RPS6KA2 | 0.48587795 |
104 | MAP2K2 | 0.48367557 |
105 | RPS6KA6 | 0.48298956 |
106 | STK10 | 0.46999405 |
107 | NEK1 | 0.45859335 |
108 | MAP2K1 | 0.45252546 |
109 | EPHB2 | 0.44123399 |
110 | DAPK3 | 0.43574490 |
111 | NME1 | 0.42364845 |
112 | STK38 | 0.42138711 |
113 | MAP3K13 | 0.41372787 |
114 | MATK | 0.40694676 |
115 | MAP2K6 | 0.40669549 |
116 | TTN | 0.39980136 |
117 | RET | 0.39538423 |
118 | LATS2 | 0.39401535 |
119 | MAP3K6 | 0.39181828 |
120 | MAP3K14 | 0.38638656 |
121 | LMTK2 | 0.37563522 |
122 | PRKD1 | 0.37301895 |
123 | PDK1 | 0.36559162 |
124 | KSR2 | 0.36460082 |
125 | ILK | 0.35814554 |
126 | MAP3K8 | 0.35053605 |
127 | PRKCI | 0.34778723 |
128 | CAMK4 | 0.34035236 |
129 | FGR | 0.33988570 |
130 | EGFR | 0.33914635 |
131 | JAK3 | 0.33853846 |
132 | PIK3CA | 0.32084049 |
133 | FGFR1 | 0.31711394 |
134 | IGF1R | 0.31114477 |
135 | DDR2 | 0.30295005 |
136 | CAMK2G | 0.30032346 |
137 | GRK1 | 0.29644083 |
138 | IKBKE | 0.29339883 |
139 | PRKG2 | 0.27574131 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.29917594 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.56569018 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.33970520 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.30513289 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99968241 |
6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72781794 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.68808333 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64669478 |
9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.63071955 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61301482 |
11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.55604147 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.51999886 |
13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.40187282 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23964870 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09141703 |
16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.06387716 |
17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.04872682 |
18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.02900894 |
19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01551936 |
20 | Peroxisome_Homo sapiens_hsa04146 | 1.98451915 |
21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.94091754 |
22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90941303 |
23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87066036 |
24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86486914 |
25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.82695402 |
26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.79926380 |
27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70578815 |
28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68444944 |
29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64454227 |
30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64372470 |
31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60174135 |
32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57536815 |
33 | Bile secretion_Homo sapiens_hsa04976 | 1.56639333 |
34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51642885 |
35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46684315 |
36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.43030438 |
37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.39803452 |
38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.39105524 |
39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38601200 |
40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37590748 |
41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32881652 |
42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26863032 |
43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.26682083 |
44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.26410702 |
45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24916799 |
46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.23458379 |
47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20579478 |
48 | ABC transporters_Homo sapiens_hsa02010 | 1.16578571 |
49 | Lysine degradation_Homo sapiens_hsa00310 | 1.02539878 |
50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00253867 |
51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98027035 |
52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.97741633 |
53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93965463 |
54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93212474 |
55 | Lysosome_Homo sapiens_hsa04142 | 0.90817746 |
56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90522774 |
57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86933990 |
58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86918951 |
59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85764035 |
60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83243352 |
61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82743913 |
62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81124316 |
63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80036422 |
64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78127804 |
65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75784437 |
66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.74456252 |
67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70441507 |
68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67150005 |
69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64761934 |
70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60895427 |
71 | Pertussis_Homo sapiens_hsa05133 | 0.54391865 |
72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51099919 |
73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40128877 |
74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38583532 |
75 | Insulin resistance_Homo sapiens_hsa04931 | 0.37518734 |
76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37370464 |
77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33700537 |
78 | Prion diseases_Homo sapiens_hsa05020 | 0.31868062 |
79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.29440567 |
80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27486365 |
81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26209594 |
82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.25180441 |
83 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.20197665 |
84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.19528952 |
85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19181439 |
86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17597807 |
87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.15351173 |
88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15056935 |
89 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.00436223 |
90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.2273802 |
91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1983507 |
92 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1971479 |
93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1926988 |
94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1672453 |
95 | Amoebiasis_Homo sapiens_hsa05146 | -0.1665912 |
96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1635586 |
97 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1607087 |
98 | Mineral absorption_Homo sapiens_hsa04978 | -0.1589968 |
99 | Hepatitis C_Homo sapiens_hsa05160 | -0.1374824 |
100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1363740 |
101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1314561 |
102 | Bladder cancer_Homo sapiens_hsa05219 | -0.1258298 |
103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1221773 |
104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1213832 |
105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0996922 |
106 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0834523 |
107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0424979 |
108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0228832 |
109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0174001 |
110 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0164906 |